Feb 26, 2026 12:51PM Stifel Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)

Feb 26, 2026 07:36AM Phathom Pharmaceuticals, Inc. (PHAT) Tops Q4 EPS by 34c

Jan 15, 2026 07:24AM Stifel Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)

Jan 14, 2026 06:59AM Phathom Pharmaceuticals (PHAT) Reiterated at Overweight at Cantor Fitzgerald

Dec 11, 2025 04:05PM Raymond James Starts Phathom Pharmaceuticals (PHAT) at Strong Buy, PT $28

Oct 30, 2025 12:03PM Phathom Pharmaceuticals (PHAT) PT Raised to $20 at Guggenheim

Oct 30, 2025 07:17AM Phathom Pharmaceuticals, Inc. (PHAT) Tops Q3 EPS by 32c, provides guidance

Oct 15, 2025 06:59AM Cantor Fitzgerald Says Phathom Pharmaceuticals (PHAT) is Top Pick After Focusing on GI

Oct 9, 2025 07:13AM Cantor Fitzgerald Reiterates Overweight Rating on Phathom Pharmaceuticals (PHAT)

Oct 6, 2025 08:00AM Phathom Pharmaceuticals names Sanjeev Narula as CFO and business officer

Aug 20, 2025 08:02AM Phathom clarifies no reduction in Frazier ownership despite filing changes

Aug 7, 2025 07:00AM Phathom Pharmaceuticals, Inc. (PHAT) Tops Q2 EPS by 12c

Jun 16, 2025 08:01AM Phathom Pharmaceuticals (PHAT) Announces FDA Correction to Orange Book Listing

Jun 9, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)

Jun 9, 2025 05:15AM Phathom Pharmaceuticals (PHAT) PT Raised to $12 at Goldman Sachs

Jun 9, 2025 03:25AM Phathom Pharmaceuticals Inc. (PHAT) call put ratio 1.5 calls to 1 put with a focus on July 7.5 calls and puts

Jun 6, 2025 01:46PM Guggenheim on Phathom Pharmaceuticals (PHAT): 'Our NPV analysis suggests fair value in the $12-14 range'

Jun 6, 2025 01:16PM Phathom Pharmaceuticals (PHAT) PT Raised to $29 at Cantor Fitzgerald

Jun 6, 2025 12:48PM Stifel Reiterates Buy Rating on Phathom (PHAT), PT $28, 'We leave our model unchanged, as our view reflected full 10-year exclusivity'

Jun 6, 2025 12:28PM Phathom Pharmaceuticals (PHAT) Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA Tablets through May 3, 2032

Jun 6, 2025 11:52AM Phathom Pharmaceuticals Inc. (PHAT) Halted on Circuit Breaker, Up 59%

Jun 6, 2025 11:51AM Phathom Pharmaceuticals (PHAT) Petition Granted by FDA

May 2, 2025 07:27AM Phathom Pharmaceuticals (PHAT) PT Lowered to $20 at H.C. Wainwright

May 1, 2025 07:06AM Phathom Pharmaceuticals, Inc. (PHAT) Tops Q1 EPS by 4c

Apr 16, 2025 08:02AM Phathom Pharmaceuticals Inc. (PHAT) Appoints Ted Schroeder to its Board of Directors

Apr 1, 2025 08:01AM Phathom Pharmaceuticals Inc. (PHAT) Announces Leadership Succession

Mar 31, 2025 08:00AM Phathom Pharmaceuticals Inc. (PHAT) : Actor and Comedian Kenan Thompson Teams Up with Phathom Pharmaceuticals to Raise Awareness About GERD and VOQUEZNA

Mar 19, 2025 02:58PM Phathom Pharmaceuticals (PHAT) PT Lowered to $13 at Jefferies

Mar 7, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)

Mar 6, 2025 04:24PM Phathom Pharmaceuticals, Inc. (PHAT) Tops Q4 EPS by 42c

Mar 6, 2025 12:25PM Stifel Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)

Feb 15, 2025 10:00PM Biotech Q4 earnings preview: Goldman Sachs

Feb 7, 2025 01:34PM Stifel Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)

Dec 12, 2024 06:44AM H.C. Wainwright Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)

Dec 11, 2024 09:38AM Stifel Comments on Phathom Pharmaceuticals Inc. (PHAT)

Nov 7, 2024 01:51PM Guggenheim Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)

Nov 7, 2024 08:08AM Phathom Pharmaceuticals, Inc. (PHAT) Tops Q3 EPS by 15c

Aug 19, 2024 08:01AM Phathom Pharmaceuticals Inc. (PHAT) Prices $130M Share and Warrant Offering at $11.50/sh

Aug 8, 2024 04:17PM Phathom Pharmaceuticals (PHAT) PT Raised to $12 at Goldman Sachs

Aug 8, 2024 02:53PM Phathom Pharmaceuticals Inc. (PHAT) spreader active in August 10 and November 10 calls

Aug 8, 2024 08:05AM Phathom Pharmaceuticals, Inc. (PHAT) Tops Q2 EPS by 7c

Jul 30, 2024 08:02AM Phathom Pharmaceuticals (PHAT) Announces VOQUEZNA Added to CVS Caremark Formularies for Commercially Insured Patients

Jul 19, 2024 10:02AM H.C. Wainwright Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)

Jul 18, 2024 08:01AM Phathom Pharmaceuticals Inc. (PHAT) Announces FDA Approval of VOQUEZNA

Apr 5, 2024 01:00PM M&A watch: 3 biotech companies that are most likely to be acquired - Needham